CJC-1295 5MG / IPAMORELIN 5MG

CJC-1295 & Ipamorelin (5 mg / 5 mg) — Research Peptide Blend

Overview
CJC-1295 and Ipamorelin are two complementary synthetic peptides widely used in laboratory and preclinical research to explore growth hormone (GH) axis regulation and somatotropic signaling. This blend pairs a growth hormone–releasing hormone (GHRH) analogue (CJC-1295 no DAC) with a growth hormone secretagogue (Ipamorelin) in a dual-mechanism formulation designed to engage distinct receptor pathways upstream of GH release.

Mechanism of Action

CJC-1295 (no DAC) is a stabilized analog of the endogenous GHRH signal that binds to the anterior pituitary’s GHRH receptors, leading to activation of adenylate cyclase and cyclic AMP–mediated pathways that support somatotropic signaling.

Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that stimulates GH release via calcium-linked signaling while exhibiting minimal activity on other pituitary hormones.

The combination harnesses two different biochemical inputs — one at the GHRH receptor and one at the ghrelin receptor — enabling researchers to investigate dual-pathway modulation of GH pulsatility, peak release patterns, and receptor dynamics in controlled experimental systems.

Typical Research Applications
This blend is suited for experimental designs focused on:

Studying pulsatile and sustained GH release models in vitro or in vivo

Examining endocrine feedback and receptor cross-talk in somatotropic pathways

Evaluating growth hormone axis dynamics, including GH/IGF-1 responses and associated signaling mechanisms

Investigating peptide synergy and modulation of hypothalamic–pituitary communication channels

Product Features

Dual peptide blend: CJC-1295 (no DAC) + Ipamorelin

Supplied as lyophilized peptide powder

Designed for research use in laboratory and preclinical settings

Provided with documentation for identity and purity verification (COA available)

Important Notice
This product is intended for laboratory research use only. It is not approved for human consumption, therapeutic application, veterinary use, or medical diagnosis. Researchers should follow all applicable safety protocols and regulatory guidelines when handling or studying peptide materials.